Showing results (1-10 of 155) with videos related to
Sort By:
Pageof 16
Therapeutische Umschau. Revue Therapeutique|March 10, 2012
[Osteoporosis: evaluation, diagnosis and monitoring]Christian Meier, Marius E KraenzlinExpert Opinion on Biological Therapy|January 27, 2006
Use of recombinant human thyroid-stimulating hormone in the management of well-differentiated thyroid cancerMarius E Kraenzlin, Christian MeierNature Reviews. Endocrinology|July 14, 2011
Parathyroid hormone analogues in the treatment of osteoporosisMarius E Kraenzlin, Christian MeierTherapeutic Advances in Musculoskeletal Disease|August 8, 2012
Antiepileptics and bone healthChristian Meier, Marius E KraenzlinCurrent Osteoporosis Reports|October 7, 2016
Effects of Incretin-Based Therapies and SGLT2 Inhibitors on Skeletal HealthAndrea Egger, Marius E Kraenzlin, Christian MeierTherapeutische Umschau. Revue Therapeutique|June 10, 2011
[Primary hyperparathyroidism]Isabelle Suter-Widmer, Marius E Kraenzlin, Christian MeierDrug Safety|September 4, 2010
Proton pump inhibitors and fracture risk: true effect or residual confounding?Michael Bodmer, Christian Meier, Marius E Kraenzlin, et al.Drug Safety|June 18, 2009
Risk of fractures with glitazones: a critical review of the evidence to dateMichael Bodmer, Christian Meier, Marius E Kraenzlin, et al.Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|April 9, 2010
Possible beneficial effect of bisphosphonates in osteonecrosis of the kneeMarius E Kraenzlin, Christian Graf, Christian Meier, et al.Journal of Bone and Mineral Metabolism|July 28, 2009
Impact of bisphosphonate wash-out prior to teriparatide therapy in clinical practiceChristina Keel, Marius E Kraenzlin, Claude A Kraenzlin, et al.Pageof 16